Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 1
1986 2
1987 2
1988 3
1989 1
1990 3
1991 1
1992 2
1993 2
1994 7
1995 4
1996 4
1997 1
1998 3
1999 1
2000 1
2001 5
2002 4
2003 3
2004 5
2005 3
2006 4
2007 2
2008 8
2009 2
2010 8
2011 9
2012 5
2013 10
2014 5
2015 14
2016 14
2017 10
2018 13
2019 7
2020 15
2021 18
2022 19
2023 17
2024 14
2025 27
2026 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

272 results

Results by year

Filters applied: . Clear all
Page 1
Drug-Induced Cognitive Impairment.
Reimers A, Odin P, Ljung H. Reimers A, et al. Among authors: odin p. Drug Saf. 2025 Apr;48(4):339-361. doi: 10.1007/s40264-024-01506-5. Epub 2024 Dec 24. Drug Saf. 2025. PMID: 39718691 Free PMC article. Review.
Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals.
Jost ST, Kaldenbach MA, Antonini A, Martinez-Martin P, Timmermann L, Odin P, Katzenschlager R, Borgohain R, Fasano A, Stocchi F, Hattori N, Kukkle PL, Rodríguez-Violante M, Falup-Pecurariu C, Schade S, Petry-Schmelzer JN, Metta V, Weintraub D, Deuschl G, Espay AJ, Tan EK, Bhidayasiri R, Fung VSC, Cardoso F, Trenkwalder C, Jenner P, Ray Chaudhuri K, Dafsari HS; International Parkinson and Movement Disorders Society Non-Motor Parkinson Disease Study Group. Jost ST, et al. Among authors: odin p. Mov Disord. 2023 Jul;38(7):1236-1252. doi: 10.1002/mds.29410. Epub 2023 May 5. Mov Disord. 2023. PMID: 37147135
Effects of a Four-Strain Probiotic on Gut Microbiota, Inflammation, and Symptoms in Parkinson's Disease: A Randomized Clinical Trial.
Leta V, Zinzalias P, Batzu L, Mandal G, Staunton J, Jernstedt F, Rosqvist K, Timpka J, van Vliet T, Trivedi D, Podlewska A, Parry M, van Wamelen DJ, Rizos A, Sportelli C, Bonder AL, Chung-Faye G, Falup-Pecurariu C, Gaisford S, Moretto E, Le Gall G, Vauzour D, Rodriguez-Mateos A, Sauerbier A, Rodriguez Blazquez C, Ghyselinck J, Marsaux B, Pariante CM, Borsini A, Odin P, Ray Chaudhuri K. Leta V, et al. Among authors: odin p. Mov Disord. 2025 Dec;40(12):2710-2721. doi: 10.1002/mds.70047. Epub 2025 Oct 23. Mov Disord. 2025. PMID: 41126787 Free PMC article. Clinical Trial.
Considerations for Initiation and Maintenance of Foslevodopa/Foscarbidopa for Advanced Parkinson's Disease.
Chaudhuri KR, Bergmans B, Freire-Alvarez E, Hopes L, Kern DS, Kirsner RS, Lazzeri G, Mendes-Bastos P, Nishikawa N, Odin P, Poplawska-Domaszewicz K, Pahwa R, Ramot Y, Seppi K, Warnecke T, Wiggins R, Shah MB, Kukreja P, Fritz B, Onuk K, Isaacson SH. Chaudhuri KR, et al. Among authors: odin p. Mov Disord Clin Pract. 2026 Jul;13(7):1601-1611. doi: 10.1002/mdc3.70489. Epub 2026 Jan 16. Mov Disord Clin Pract. 2026. PMID: 41540973 Free PMC article. Review.
Is levodopa toxic?
Müller T, Hefter H, Hueber R, Jost WH, Leenders KL, Odin P, Schwarz J. Müller T, et al. Among authors: odin p. J Neurol. 2004 Sep;251 Suppl 6:VI/44-6. doi: 10.1007/s00415-004-1610-x. J Neurol. 2004. PMID: 15675725 Review.
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study.
Olanow CW, Kieburtz K, Odin P, Espay AJ, Standaert DG, Fernandez HH, Vanagunas A, Othman AA, Widnell KL, Robieson WZ, Pritchett Y, Chatamra K, Benesh J, Lenz RA, Antonini A; LCIG Horizon Study Group. Olanow CW, et al. Among authors: odin p. Lancet Neurol. 2014 Feb;13(2):141-9. doi: 10.1016/S1474-4422(13)70293-X. Epub 2013 Dec 20. Lancet Neurol. 2014. PMID: 24361112 Free PMC article. Clinical Trial.
3.1 Levodopa infusion for Parkinson's disease.
Odin P, Rosqvist K. Odin P, et al. In: Odin P, Chaudhuri KR, Aquilonious SM, Mundt-Petersen U, editors. Where are We? Continuous Dopaminergic Stimulation for Parkinson's Disease [Internet]. Berkshire (UK): Empowering Strategic Performance Ltd; 2023 Jan 1. In: Odin P, Chaudhuri KR, Aquilonious SM, Mundt-Petersen U, editors. Where are We? Continuous Dopaminergic Stimulation for Parkinson's Disease [Internet]. Berkshire (UK): Empowering Strategic Performance Ltd; 2023 Jan 1. PMID: 39208173 Free Books & Documents. Review. No abstract available.
Infusion therapies for Parkinson's disease: where are we in 2025?
Rigon L, Fogliano C, Odin P, Antonini A. Rigon L, et al. Among authors: odin p. Expert Opin Drug Deliv. 2026 Feb;23(2):187-190. doi: 10.1080/17425247.2025.2577710. Epub 2025 Oct 21. Expert Opin Drug Deliv. 2026. PMID: 41105663 No abstract available.
272 results